AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglyn M IR 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglyn M IR 50/1000 Tablet

Metformin/glimepiride tablets (50/1000 mg) manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. This medication may be prescribed independently or alongside other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is tailored to individual health status, blood glucose readings, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a possible adverse effect, especially when used with insulin or sulfonylureas; appropriate management strategies should be understood. This medication is not universally suitable. Individuals with pre-existing hepatic, renal, or cardiac conditions, pancreatic disorders, or significant alcohol consumption should discuss use with their physician. Pregnant or lactating women should consult their doctor. Inform your doctor about all other medications being taken to ensure safe concurrent use. Alcohol should be avoided due to its hypoglycemic effects. Kidney function and blood glucose will be monitored before and throughout treatment.

Primary Ingredients of Sitaglyn M IR 50/1000 Tablet

The provided text is "undefined". Therefore, no rephrasing is possible.

Uses of Sitaglyn M IR 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitaglyn M IR 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaglyn M IR 50/1000 with a meal.

Common Side effects of Sitaglyn M IR 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglyn M IR 50/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitaglyn M IR 50/1000 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitaglyn M IR 50/1000 Tablet works:

Sitaglyn M IR 50/1000 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglyn M IR 50/1000 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglyn M IR 50/1000 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Sitaglyn M IR 50/1000 Tablets. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglyn M IR 50/1000 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaglyn M IR 50/1000 Tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Sitaglyn M IR 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaglyn M IR 50/1000 Tablet :

Should you forget a Sitaglyn M IR 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglyn M IR 50/1000 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitaglyn M IR 50/1000 Tablet

Sitaglyn M IR 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitaglyn M IR 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaglyn M IR 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglyn M IR 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaglyn M IR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaglyn M IR 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglyn M IR 50/1000 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It enhances blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M IR 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaglyn M IR 50/1000 Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M IR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M IR 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglyn M IR 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitaglyn M IR 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitaglyn M IR 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaglyn M IR 50/1000 Tablets are contraindicated in patients with known allergies to its ingredients or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M IR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M IR 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglyn M IR 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Annual supplemental vitamin B12 intake is recommended by some researchers to mitigate these risks.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglyn M IR 50/1000 Tab...
124